Publications by authors named "Emily Bethea"

Claim this Profile
R
Real-World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression.
Kathleen E Corey, Nabih Nakrour, Emily D Bethea, Jessica E Shay, Karin L Andersson

Liver Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Transplant Provider Perspectives on Posttransplant Management of Alcohol Use Disorder.
Maria P Cote, Daniel Cloonan, Sienna Li, Shahaan Razak, Ruby Singh, Emily Bethea

Transplant Direct· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial burden following adult liver transplantation is common and associated with adverse recipient outcomes.
Nneka N Ufere, Marina Serper, Alyson Kaplan, Nora Horick, Teresa Indriolo, Emily Bethea

Liver Transpl· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proximal splenic artery embolization for treatment of refractory ascites, a single-center experience.
Abdul Rehman Mustafa, Raneem Atta, Russell P Goodman, Vincent Wu, Zubin Irani, Emily D Bethea

Hepatol Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapidly Progressive Pulmonary Lymphangitic Carcinomatosis After Liver Transplantation Due to Diffuse Infiltrative Sarcomatoid Hepatocellular Carcinoma.
Tsukasa Nakamura, Richard Teo, Angela R Shih, Katherine Latham, Emily D Bethea

Transplant Direct· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-center experience with early liver transplantation for acute alcohol-related hepatitis-Limitations of the SALT score and directions for future study.
Ana Ivkovic, Mladen Nisavic, Alexander H Yang, Diana Punko, Ashley Elizabeth Aaron, Emily D Bethea

Clin Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care-related transportation insecurity is associated with adverse health outcomes among adults with chronic liver disease.
Nneka N Ufere, Carlos Lago-Hernandez, Alysa Alejandro-Soto, Tiana Walker, Lucinda Li, Emily Bethea

Hepatol Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis.
Srilakshmi Atthota, Kayla Joyal, Mariesa Cote, Riley Scalzo, Ruby Singh, Emily D Bethea

Front Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferred language and disease severity predict evaluation for liver transplantation among patients admitted with alcohol-associated hepatitis.
Daniel J Cloonan, Jordan M Broekhuis, Taylor M Coe, Steven Criss, Sienna Li, Emily D Bethea

Eur J Gastroenterol Hepatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence and natural history of ascites after liver transplantation.
Patricia P Bloom, Timothy Gilbert, Keli Santos-Parker, Zoe Memel, Eric Przybyszewski, Emily Bethea

Hepatol Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response.
Mauricio A Villavicencio, Selena S Li, Ann Marie Leifer, Jenna L Gustafson, Asishana Osho, Emily Bethea

JTCVS Open· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
Surendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, Aparna Govindan, Lei Zhao, Emily Bethea

Oncologist· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
Ayman Al Jurdi, Leela Morena, Mariesa Cote, Emily Bethea, Jamil Azzi

Am J Transplant· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease.
Jagpreet Chhatwal, Ozden O Dalgic, Wanyi Chen, Sumeyye Samur, Emily D Bethea

JAMA Netw Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.
Peter P Mueller, Qiushi Chen, Turgay Ayer, Gizem S Nemutlu, Ali Hajjar, Emily D Bethea

J Hepatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation.
Qing Yuan, Omar Haque, Shanjuan Hong, Andric Ortiz, Emily D Bethea

Clin Transplant· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus.
Qing Yuan, Hanwen Cui, Greg A Leya, Shanjuan Hong, Eve M Roth, Emily D Bethea

Transpl Int· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation with suprahepatic caval anastomosis including inferior vena cava stent.
Taylor M Coe, Mari Tanaka, Emily D Bethea, David A D'Alessandro, Shoko Kimura

Transpl Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transjugular Intrahepatic Portosystemic Shunt Placement for Portal Hypertension: Meta-Analysis of Safety and Efficacy of 8 mm vs. 10 mm Stents.
Jiangtao Liu, Eric Paul Wehrenberg-Klee, Emily D Bethea, Raul N Uppot, Kei Yamada

Gastroenterol Res Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.
Emily Bethea, Ashwini Arvind, Jenna Gustafson, Karin Andersson, Daniel Pratt

Am J Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.
Jovan Julien, Turgay Ayer, Emily D Bethea, Elliot B Tapper, Jagpreet Chhatwal

Lancet Public Health· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
Yanik J Bababekov, Ya-Ching Hung, David C Chang, Charles G Rickert, Joel T Adler, Emily Bethea

Transplantation· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residents Take the Lead: A Modern Collaborative Approach to Research During Residency.
Alev J Atalay, Kevin Ard, Emily Bethea, Kenneth B Christopher, Maria A Yialamas

Adv Med Educ Pract· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes.
Patricia P Bloom, Amirkasra Mojtahed, Emily D Bethea, Sally A Knooihuizen, Jin Choi

Dig Dis Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
Emily D Bethea, Kerry Gaj, Jenna L Gustafson, Andrea Axtell, Taylor Lebeis

Lancet Gastroenterol Hepatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis